Best of October: Top 5 Insights In Clinical Trial Technology

#1 - What's The Deal With eConsent?

Are you for or against eConsent? It’s odd that this technology has kind of become a polarizing topic in the clinical trials industry. To find out why, Chief Editor Dan Schell decided to get some feedback from folks who have actually used it.

#2 - How Will IQVIA One Home for Sites™ Simplify Clinical Trial Technology? Q&A For Sponsors, Partners, And Sites

IQVIA Technologies leaders answer questions from sponsors, sites, CROs, and tech vendors about One Home for Sites, an aggregation platform that provides single sign-on across sponsors, studies, and systems.

#3 - KPIs To Consider When Evaluating Success With New Site Technology

Once trial staff begins to embrace a new technology, the sponsor should concentrate on the technology’s performance and how it positively impacts the organization's key performance indicators (KPIs). Consultant Aurea Flores, Ph.D., offers specific advice for evaluating whether a new technology is embraced by site staff and fulfilling its purpose for the sponsor.

#4 - Say No To Vaporware – 10 Questions To Ask When Looking For An eClinical Platform

Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.

#5 - Is Blockchain The Solution To Derisking Unreliable Clinical Trial Data?

Technological advances have provided fertile ground for scientific fraud, but blockchain just may be the key to ensuring a transparent, trusted, and certified process for collecting, managing, and analyzing clinical trial data.